Detalhe da pesquisa
1.
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
N Engl J Med
; 389(22): 2039-2051, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870976
2.
Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation.
N Engl J Med
; 387(2): 120-131, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35658005
3.
Matching-adjusted indirect comparison of amivantamab vs mobocertinib in platinum-pretreated EGFR Exon 20 insertion-mutated non-small-cell lung cancer.
Future Oncol
; 20(8): 447-458, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882460
4.
Presentation, Diagnosis and Management of Innominate Artery Thromboembolism.
J Endovasc Ther
; 29(3): 451-456, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34704504
5.
Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas.
Mod Pathol
; 34(12): 2168-2174, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34362997
6.
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.
Invest New Drugs
; 39(5): 1284-1297, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852104
7.
Hitting the Right Spot: Advances in the Treatment of NSCLC With Uncommon EGFR Mutations.
J Natl Compr Canc Netw
; 19(Suppl_2): S1-S11, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34875627
8.
Adagrasib in Non-Small-Cell Lung Cancer. Reply.
N Engl J Med
; 387(13): 1238-1239, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170509
9.
Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices.
Mod Pathol
; 32(8): 1106-1122, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923345
10.
Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations.
Mod Pathol
; 31(1): 111-121, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28884744
11.
Changing the Therapeutic Landscape in Non-small Cell Lung Cancers: the Evolution of Comprehensive Molecular Profiling Improves Access to Therapy.
Curr Oncol Rep
; 19(4): 24, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28303491
12.
Selective Personalized RadioImmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial (SPRINT).
J Clin Oncol
; 42(5): 562-570, 2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988638
13.
Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer.
Cancer Discov
; 14(6): 982-993, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38587856
14.
Combinatorial therapy is a safe and durable treatment option in ALK-rearranged non-small cell lung cancer with an acquired MET exon 14 skipping mutation mediated resistance to alectinib: a case report.
Transl Lung Cancer Res
; 12(12): 2558-2564, 2023 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38205199
15.
Amivantamab, an Epidermal Growth Factor Receptor (EGFR) and Mesenchymal-epithelial Transition Factor (MET) Bispecific Antibody, Designed to Enable Multiple Mechanisms of Action and Broad Clinical Applications.
Clin Lung Cancer
; 24(2): 89-97, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36481319
16.
Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced KRAS G12C-Mutant Non-Small Cell Lung Cancer.
JCO Precis Oncol
; 7: e2300030, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384866
17.
Intracranial Efficacy of Adagrasib in Patients From the KRYSTAL-1 Trial With KRASG12C-Mutated Non-Small-Cell Lung Cancer Who Have Untreated CNS Metastases.
J Clin Oncol
; 41(28): 4472-4477, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327468
18.
Extended Survival in Patients With Non-Small-Cell Lung Cancer-Associated Brain Metastases in the Modern Era.
Neurosurgery
; 93(1): 50-59, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722962
19.
Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation.
J Clin Oncol
; 41(25): 4097-4106, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099736
20.
Management of infusion-related reactions (IRRs) in patients receiving amivantamab in the CHRYSALIS study.
Lung Cancer
; 178: 166-171, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868177